Miglitol

Miglitol inhibits the breakdown complex carbohydrates into glucose. It is mainly used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (including disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body. Miglitol should be taken at the start of a meal for maximal effect and the effect will depend on the amount of poly and oligosaccharides in the diet. Miglitol inhibits alpha-glucosidase, making less sugars available for digestion and reducing postprandial hyperglycemia. Unlike other drugs of the same class, miglitol is not metabolized and the unmetabolized drug is excreted by the kidneys. It is grouped under the following drug class(es): Carbohydrates and Hypoglycemics. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Glyset, Seibule, Plumarol and Diastabol. Its PubChem CID is 441314.

CAS No 72432-03-2
Molecular Formula C8H17NO5
Molecular Weight 207.22 g/mol
Synonyms (2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol

Frequently Asked Questions